As far as I can see 114 days have already passed , the Novartis deal was signed on the 19th November , the deal seems only subject to the expiration or termination of the waiting period under the heart scott-Rodino Antitrust Improvement Act and other certain conditions ?? I do not think Novartis is in control of this timing or could or want to withdraw ? am I missing something ? who knows ?
Melbourne, Australia; November 20, and New York, USA; November 19, 2020: Mesoblast Limited (ASX:MSB; Nasdaq:MESO), today announced that it has entered into an exclusive worldwide license and collaboration agreement with Novartis for the development, manufacture and commercialization of Mesoblast’s mesenchymal stromal cell (MSC) product remestemcel-L, with an initial focus on the development of the treatment of acute respiratory distress syndrome (ARDS), including that associated with COVID-19.
The closing of the license agreement is subject to the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act and certain other conditions.
ARDS is an area of significant unmet need, with a high mortality rate despite current standard of care, which includes prolonged ICU treatment and mechanical ventilation. As the potential first ARDS therapy, remestemcel-L will be evaluated to treat this deadly condition and improve outcomes. Remestemcel-L is currently being studied in COVID-19-related ARDS in an ongoing 300-patient Phase 3 study, where even with maximal existing therapies, mortality is estimated to be even higher. Novartis intends to initiate a Phase 3 study in non-COVID-19-related ARDS after the anticipated closing of the license agreement and successful completion and outcome of the current study.
- Forums
- ASX - By Stock
- Deadline for Novartis
As far as I can see 114 days have already passed , the Novartis...
-
-
- There are more pages in this discussion • 427 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.5¢ |
Change
0.005(0.53%) |
Mkt cap ! $1.081B |
Open | High | Low | Value | Volume |
95.0¢ | 95.8¢ | 93.5¢ | $423.6K | 447.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 54888 | 95.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.5¢ | 20170 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 58136 | 0.950 |
19 | 75989 | 0.945 |
13 | 65582 | 0.940 |
11 | 128902 | 0.935 |
12 | 129950 | 0.930 |
Price($) | Vol. | No. |
---|---|---|
0.955 | 207 | 3 |
0.960 | 61170 | 13 |
0.965 | 57439 | 7 |
0.970 | 62220 | 9 |
0.975 | 143718 | 8 |
Last trade - 11.00am 28/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online